Fiscal Year 2024 GuidanceThe table below summarizes our fiscal year 2024 guidance and represents our views as of January 24, 2024. Our revenue guidance reflects approximately $200 million of higher-than-expected material
ediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova's Chief Medical
The story of Puffco is the story of a man, his time and place, his passion for hashish, and a team of creatives pushing his company forward. And it all started as a hobby when Vape pens set the scene in New York in 2012.